Public company Artelo launches Solana reserve asset strategy

2025-08-04 20:20:16

Collection

ChainCatcher news, according to GlobeNewswire, clinical-stage pharmaceutical company Artelo Biosciences (NASDAQ: ARTL) announced the completion of a $9.475 million private placement, which will be used to initiate a digital asset reserve strategy centered around Solana (SOL). The company becomes the first publicly traded pharmaceutical enterprise to include SOL in its reserve assets.

The private placement includes the issuance of common stock (or pre-funded warrants) at a price of $10.45 per share, as well as two tranches of three-year warrants with exercise prices of $10.20 and $50. The transaction is expected to be completed on August 5, 2025.

(Source Link)

Risk warning

Related tags

Artelo publicly traded company Solana

During the cryptocurrency market, a record of institutional crypto holdings and capital operations.

Recently, stablecoin concept stocks have continued to strengthen, with several listed companies establishing reserves of crypto assets. Stocks of crypto companies are becoming a special "crypto hotspot": traditional market investors are beginning to pay attention to companies in the crypto industry, while those in the crypto circle view the price changes of crypto stocks as one of the indicators of market fluctuations. This topic will continue to focus on the dynamics of related projects, institutional movements, market performance, and the strategic logic behind them, gaining insights into the development path of this wave of integration between crypto and equity.

Topic or theme